Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,889,175
+$174,417 QoQ
Shares Held
19,251
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.47%
of 13F equity value
Holder Rank
#1,633
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 24%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. JNJ ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
|
1,703 | $266,893 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,889,175 | 19,251 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,714,758 | 19,288 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,025,176 | 19,450 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,740,476 | 20,173 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,999,551 | 19,637 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,324,096 | 20,044 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,905,994 | 20,094 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,300,027 | 20,363 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $3,419,997 | 23,399 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,758,593 | 23,760 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,877,119 | 24,736 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,867,895 | 24,834 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,158,358 | 25,123 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $3,953,740 | 25,508 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $4,530,365 | 25,646 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $4,185,772 | 25,623 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $4,552,243 | 25,645 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $4,574,128 | 25,809 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $4,540,710 | 26,543 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $4,314,957 | 26,718 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,434,471 | 26,918 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,447,803 | 27,063 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $4,293,798 | 27,283 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $3,997,130 | 26,848 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $3,761,570 | 26,748 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $3,453,701 | 26,338 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||